|
1
|
Subcutaneous administration of amifostine during fractionated radiotherapy: a randomized phase II study.
|
J Clin Oncol
|
2000
|
1.78
|
|
2
|
First-line chemotherapy with docetaxel for unresectable or metastatic carcinoma of the biliary tract. A multicentre phase II study.
|
Eur J Cancer
|
2001
|
1.11
|
|
3
|
A multicenter randomized clinical trial comparing paclitaxel-cisplatin-etoposide versus cisplatin-etoposide as first-line treatment in patients with small-cell lung cancer.
|
Ann Oncol
|
2001
|
1.09
|
|
4
|
Combination of irinotecan (CPT-11) plus 5-fluorouracil and leucovorin (FOLFIRI regimen) as first line treatment for elderly patients with metastatic colorectal cancer: a phase II trial.
|
Oncology
|
2005
|
1.06
|
|
5
|
Peripheral blood circulating cytokeratin-19 mRNA-positive cells after the completion of adjuvant chemotherapy in patients with operable breast cancer.
|
Ann Oncol
|
2003
|
1.05
|
|
6
|
Temozolomide and cisplatin versus temozolomide in patients with advanced melanoma: a randomized phase II study of the Hellenic Cooperative Oncology Group.
|
Ann Oncol
|
2005
|
1.04
|
|
7
|
Treatment of pancreatic cancer with a combination of docetaxel, gemcitabine and granulocyte colony-stimulating factor: a phase II study of the Greek Cooperative Group for Pancreatic Cancer.
|
Ann Oncol
|
2001
|
1.03
|
|
8
|
Front-line treatment of advanced non-small-cell lung cancer with docetaxel and gemcitabine: a multicenter phase II trial.
|
J Clin Oncol
|
1999
|
1.00
|
|
9
|
Treatment of pancreatic cancer with a combination of irinotecan (CPT-11) and gemcitabine: a multicenter phase II study by the Greek Cooperative Group for Pancreatic Cancer.
|
Ann Oncol
|
2003
|
0.93
|
|
10
|
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumors.
|
Ann Oncol
|
2003
|
0.87
|
|
11
|
Front-line treatment of advanced breast cancer with docetaxel and epirubicin: a multicenter phase II study.
|
Ann Oncol
|
2000
|
0.87
|
|
12
|
Irinotecan plus gemcitabine vs irinotecan for the second-line treatment of patients with advanced non-small-cell lung cancer pretreated with docetaxel and cisplatin: a multicentre, randomised, phase II study.
|
Br J Cancer
|
2004
|
0.87
|
|
13
|
Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: a multicenter phase II study.
|
Ann Oncol
|
1998
|
0.84
|
|
14
|
Phase I study of weekly paclitaxel and liposomal doxorubicin in patients with advanced solid tumours.
|
Eur J Cancer
|
2002
|
0.84
|
|
15
|
Docetaxel and granulocyte colony-stimulating factor in patients with advanced non-small-cell lung cancer previously treated with platinum-based chemotherapy: a multicenter phase II trial.
|
Cancer Chemother Pharmacol
|
1999
|
0.83
|
|
16
|
Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer.
|
Cancer
|
2001
|
0.81
|
|
17
|
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer.
|
Ann Oncol
|
2009
|
0.80
|
|
18
|
Comparison of docetaxel/cisplatin to docetaxel/gemcitabine as first-line treatment of advanced non-small cell lung cancer: early results of a randomized trial.
|
Lung Cancer
|
2001
|
0.80
|
|
19
|
Cisplatin and irinotecan (CPT-11) as second-line treatment in patients with advanced non-small cell lung cancer.
|
Lung Cancer
|
2001
|
0.79
|
|
20
|
ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program.
|
Lung Cancer
|
2003
|
0.79
|
|
21
|
Irinotecan (CPT-11) in combination with infusional 5-fluorouracil and leucovorin (de Gramont regimen) as first-line treatment in patients with advanced colorectal cancer: a multicenter phase II study.
|
Am J Clin Oncol
|
2002
|
0.78
|
|
22
|
Second-line treatment with vinorelbine and carboplatin in patients with advanced non-small cell lung cancer. A multicenter phase II study.
|
Lung Cancer
|
2001
|
0.77
|
|
23
|
Dose escalation study on oxaliplatin and capecitabine (Xeloda) in patients with advanced solid tumors.
|
Oncology
|
2004
|
0.77
|
|
24
|
Combination chemotherapy with docetaxel, vinorelbine and cisplatin as first-line treatment of advanced non-small-cell lung cancer: a multicenter phase II study of the Greek Cooperative Group for Lung Cancer.
|
Lung Cancer
|
1998
|
0.76
|
|
25
|
A dose-finding study of irinotecan (CPT-11) plus a four-day continuous 5-fluorouracil infusion in advanced colorectal cancer.
|
Oncology
|
2001
|
0.76
|
|
26
|
Salvage chemotherapy with high-dose leucovorin (LV) and 48-hour continuous infusion (CI) of 5-fluorouracil (5-FU) in combination with conventional doses of cyclophosphamide (CPM) in patients with metastatic breast cancer (MBC) pretreated with anthracycline and taxanes.
|
Br J Cancer
|
2001
|
0.75
|
|
27
|
Docetaxel in combination with mitoxantrone and granulocyte colony-stimulating factor as front-line chemotherapy in metastatic breast cancer: a multicenter phase II study.
|
Ann Oncol
|
2001
|
0.75
|
|
28
|
Carcinoma of sigmoid colon after ureterosigmoidostomy.
|
J BUON
|
2007
|
0.75
|
|
29
|
Salvage treatment of advanced non-small-cell lung cancer previously treated with docetaxel-based front-line chemotherapy with irinotecan (CPT-11) in combination with cisplatin.
|
Ann Oncol
|
2000
|
0.75
|
|
30
|
A dose escalation study of topotecan in combination with epirubicin in pretreated patients with small-cell lung cancer.
|
Lung Cancer
|
2001
|
0.75
|
|
31
|
A dose-escalation study of oxaliplatin and vinorelbine in patients with advanced solid tumors.
|
Oncology
|
2002
|
0.75
|
|
32
|
Docetaxel in combination with gemcitabine plus rhG-CSF support as second-line treatment in non-small cell lung cancer. A multicenter phase II study.
|
Lung Cancer
|
2001
|
0.75
|
|
33
|
Malignant peripheral nerve-sheath tumor of the left cerebello-pontine angle: case report.
|
J BUON
|
2007
|
0.75
|
|
34
|
Vinorelbine-based regimens as salvage treatment in patients with advanced non-small cell lung cancer: two parallel multicenter phase II trials.
|
Oncology
|
2001
|
0.75
|
|
35
|
A phase I clinical trial of topotecan given every 2 weeks in patients with refractory solid tumors.
|
Oncology
|
2001
|
0.75
|